Skip to content

OS Therapies OSTX Warrants Exercised And Proceeds Received Shares Pending Issuance

Warrants Exercised And Proceeds Received Shares Pending Issuance at other companies

Tidewater logo
TidewaterTDW
$0-100%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$7.44M+743,800%
KEE
Keel Infrastructure Corp. Common StockKEEL
$11.48M
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
DJT
Trump Media & Technology GroupDJT
$80.5K-57.5%
Envoy Medical logo
Envoy MedicalCOCH
$2.95M+114%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:WarrantsExercisedAndProceedsReceivedSharesPendingIssuance.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's warrants exercised and proceeds received shares pending issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's warrants exercised and proceeds received shares pending issuance?
OS Therapies (OSTX) reported warrants exercised and proceeds received shares pending issuance of $567.4K in Q1 2026.
How has OS Therapies's warrants exercised and proceeds received shares pending issuance changed year-over-year?
OS Therapies's warrants exercised and proceeds received shares pending issuance increased by 43.7% year-over-year, from $394.97K to $567.4K.
What does warrants exercised and proceeds received shares pending issuance mean?
Cash proceeds received from the exercise of warrants where the underlying shares are pending formal issuance. This tracks immediate liquidity inflows from the exercise of equity-linked derivatives.